Drugs / CD117 stem cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT06841068 | Feb → Aug 2026 | multiple sclerosis | Wake Forest University Health Sciences | Withdrawn | No outcome recorded Stop: Business |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD117 stem cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06841068 ↗ |
| Modality | Cell therapy | “CD117 (c-Kit) positive stem cells, extracted from ethical fetal sources such as amniotic fluid and placental tissue.” NCT06841068 ↗ |
| Route | Intrathecal | “4 intrathecal injections of c-Kit stem cells” NCT06841068 ↗ |